Takashi Iizumi, Toshiyuki Okumura, Naoyuki Hasegawa, Kazunori Ishige, Kuniaki Fukuda, Emiko Seo, Hirokazu Makishima, Hikaru Niitsu, Mizuki Takahashi, Yuta Sekino, Hiroaki Takahashi, Daichi Takizawa, Yoshiko Oshiro, Keiichiro Baba, Motohiro Murakami, Takashi Saito, Haruko Numajiri, Masashi Mizumoto, Kei Nakai, Hideyuki Sakurai
AIM: Hepatocellular carcinoma (HCC) with bile duct invasion (BDI) (BDIHCC) has a poor prognosis. Moreover, due to the paucity of reports, there is no consensus regarding optimal management of this clinical condition yet. The aim of this study was to clarify the efficacy and safety of proton beam therapy (PBT) for BDIHCC. METHODS: Between 2009 and 2018, 15 patients with BDIHCC underwent PBT at our institution. The overall survival (OS), local control (LC), and progression-free survival (PFS) curves were constructed using the Kaplan-Meier method...
August 3, 2023: BMC Gastroenterology